Pulmokine

Pulmokine is a company dedicated to developing innovative respiratory health solutions aimed at improving the quality of life for individuals suffering from breathing difficulties.Founded in 2007 and headquartered in Rensselaer, US, Pulmokine specializes in respiratory health products.00 mn from Broadview Ventures on March 3, 2015.Pulmokine specializes in innovative respiratory health solutions designed to enhance the quality of life for individuals with breathing difficulties. Their primary product offerings include proprietary formulations that aim to alleviate respiratory conditions by improving lung function and easing breathability. These products target patients suffering from chronic respiratory diseases, such as asthma and COPD, as well as individuals seeking preventive measures for respiratory health. Pulmokine's solutions are developed with a focus on efficacy and user experience, ensuring they meet the needs of both healthcare professionals and end consumers.Pulmokine generates revenue through a direct-to-consumer model, offering its products through online platforms and retail partnerships. The company has established a pricing structure that allows for individual sales, as well as potential subscription models for ongoing customer engagement. Through these transactions, Pulmokine ensures a consistent supply of their flagship respiratory health products, designed to address specific health concerns. Each transaction facilitates ease of purchase for consumers and enables partnerships with healthcare facilities to enhance product accessibility.Pulmokine is focused on designing and launching new respiratory health products in the upcoming period to expand its offerings. The company is also planning to enter new geographic markets, specifically targeting regions across Asia by the end of 2025.

1. Seed

   Mar 3, 2015

   Amount

   $1M

   Investors

   Locked